|
51
|
245
|
5zahU |
Upa-bb2-30f |
|
59
|
245
|
5z1cU |
The crystal structure of upa in complex with 4-iodobenzylamine at ph7.4 |
|
56
|
245
|
5za9U |
Upa-bb2-50f |
|
54
|
227
|
6qfeA |
Crystal structure of human kallikrein 5 in complex with gsk144 |
|
55
|
223
|
6qfgA |
Crystal structure of human kallikrein 6 (i218y) in complex with gsk144 |
|
53
|
222
|
6qffA |
Crystal structure of human kallikrein 6 in complex with gsk144 |
|
53
|
222
|
6qfhA |
Crystal structure of human kallikrein 6 (n217d/i218y/k224r) in complex with gsk144. |
|
67
|
258
|
5do4H |
Thrombin-rna aptamer complex |
|
68
|
259
|
6eo6H |
X-ray structure of the complex between human alpha-thrombin and modified 15-mer dna aptamer containing 5-(3-(2-(1h-indol-3-yl)acetamide-n-yl)-1-propen-1-yl)-2'-deoxyuridine residue |
|
60
|
230
|
6qmrA |
Complement factor d in complex with the inhibitor (s)-2-(2-((3'-(1-amino-2-hydroxyethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)acetic acid |
|
57
|
230
|
6qmtA |
Complement factor d in complex with the inhibitor 2-(2-(3'-(aminomethyl)-[1,1'-biphenyl]-3-carboxamido)phenyl)acetic acid |
|
57
|
257
|
6gbwH |
Thrombin in complex with mi2100 ((s)-n-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-l-arginyl)pyrrolidine-2-carboxamide) |
|
47
|
251
|
5zlzE |
Structure of tpa and pai-1 |
|
63
|
233
|
5vofH |
Desgla-xas195a bound to aptamer 11f7t and rivaroxaban |
|
120
|
466
|
5ilbA |
Crystal structure of protease domain of deg2 linked with the pdz domain of deg9 |
|
53
|
223
|
3uqvA |
Bovine trypsin variant x(triplephe227) in complex with small molecule inhibitor |
|
53
|
223
|
3unrA |
Bond length analysis of asp, glu and his residues in trypsin at 1.2a resolution |
|
59
|
234
|
3s9cA |
Russell's viper venom serine proteinase, rvv-v in complex with the fragment (residues 1533-1546) of human factor v |
|
62
|
223
|
3tgiE |
Wild-type rat anionic trypsin complexed with bovine pancreatic trypsin inhibitor (bpti) |
|
47
|
226
|
3s0nA |
Crystal structure of human chymase with benzimidazolone inhibitor |
|
55
|
234
|
3s9bA |
Russell's viper venom serine proteinase, rvv-v (open-form) |
|
53
|
224
|
3tgjE |
S195a trypsinogen complexed with bovine pancreatic trypsin inhibitor (bpti) |
|
50
|
256
|
3s7hB |
Structure of thrombin mutant y225p in the e* form |
|
62
|
233
|
5voeH |
Desgla-xas195a bound to aptamer 11f7t |
|
59
|
224
|
5zfiA |
Mouse kallikrein 7 in complex with 6-benzyl-1,4-diazepan-7-one derivative |
|
57
|
223
|
5xwjA |
Crystal structure of porcine pancreatic trypsin with tripeptide inhibitor, tre, at ph 7 |
|
50
|
238
|
5qclA |
Factor xia in complex with the inhibitor 4-[[(1~{s})-2-[(~{e})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{h}-isoquinolin-1-yl]carbonylamino]benzoic acid |
|
50
|
238
|
5qcnA |
Factor xia in complex with the inhibitor 4-[[(1~{s})-2-[(~{e})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-5-[(3~{s})-3-ethoxycarbonylpiperidin-1-yl]carbonyl-3,4-dihydro-1~{h}-isoquinolin-1-yl]carbonylamino]benzoic acid |
|
67
|
337
|
5t69A |
The hhoa protease from synechocystis sp. pcc 6803, active site mutant |
|
53
|
181
|
5sgaE |
Structures of product and inhibitor complexes of streptomyces griseus protease a at 1.8 angstroms resolution. a model for serine protease catalysis |
|
51
|
238
|
5q0eA |
Factor xia in complex with the inhibitor methyl [(4s,8s)-8-({(2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-4-methyl-2-oxo-1,3,4,5,6,7,8,10-octahydro-2h-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate |
|
52
|
238
|
5q0hA |
Factor xia in complex with the inhibitor methyl [(4r,5e,8s)-11-chloro-8-[(2,6-difluoro-4-methylbenzene-1-carbonyl)amino]-4-methyl-2-oxo-1,3,4,7,8,10-hexahydro-2h-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate |
|
58
|
230
|
5nb7A |
Complement factor d |
|
58
|
228
|
5nawA |
Complement factor d in complex with the inhibitor (1r,3s,5r)-2-aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic acid 2-[(1-carbamoyl-1h-indol-3-yl)-amide] 3-[(3-trifluoromethoxy-phenyl)-amide] |
|
61
|
230
|
5nbaA |
Complement factor d in complex with the inhibitor (2s,4r)-4-fluoro-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1h-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] |
|
58
|
230
|
5narA |
Complement factor d in complex with the inhibitor (s)-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1h-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] |
|
56
|
230
|
5nb6A |
Complement factor d in complex with the inhibitor (2s,4s)-4-amino-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1h-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] |
|
54
|
228
|
5mt4A |
Complement factor d in complex with a reversible benzoic acid based inhibitor |
|
59
|
228
|
5natA |
Complement factor d in complex with the inhibitor (s)-pyrrolidine-1,2-dicarboxylic acid 1-[(1-methyl-1h-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] |
|
60
|
223
|
5mn1A |
Cationic trypsin in complex with 2-aminopyridine (deuterated sample at 100 k) |
|
50
|
228
|
5ms3A |
Kallikrein-related peptidase 8 calcium complex |
|
63
|
223
|
5mosA |
Joint x-ray/neutron structure of cationic trypsin in complex with n-amidinopiperidine |
|
62
|
223
|
5mnbA |
Cationic trypsin in complex with 2-aminopyridine (deuterated sample at 295 k) |
|
56
|
223
|
5mo0A |
Neutron structure of cationic trypsin in complex with benzamidine |
|
57
|
257
|
5mlsH |
Thrombin mutant a190s in complex with (s)-1-(d-phenylalanyl)-n-(3-chlorobenzyl)pyrrolidine-2-carboxamide |
|
61
|
223
|
5mnmA |
Cationic trypsin in complex with benzylamine (at 295 k) |
|
56
|
257
|
5mjtH |
Thrombin mutant a190s in complex with (s) -1 - ((r) -2-amino-3,3-diphenylpropanoyl) -n- (3-chlorobenzyl) pyrrolidine-2-carboxamide |
|
58
|
230
|
5mt0A |
Complement factor d in complex with a reversible indole carboxylic acid based inhibitor |
|
62
|
223
|
5mneA |
Cationic trypsin in its apo form (deuterated sample at 100 k) |
|
58
|
204
|
5mm8A |
Atomic resolution structure of sple protease from staphylococcus aureus |
